9. Blood glucose disorders in elderly patients with stented coronary arteries

Ho Thi Kim Thanh, Le Van Cuong, Le Thi Hoai

Main Article Content

Abstract

This is a cross sectional descriptive study of blood glucose disorders of elderly patients with stented coronary arteries treated at Thanh Hoa Provincial General Hospital. In 87 patients over 60 years of age who had coronary artery stent implanted in 2021 66.6% were pre-diabetic, where fasting blood sugar disorder accounted for 19.54%, a reduction of Glucose tolerance after oral glucose tolerance test accounted for 19.54% and 51.72% of the patients had diabetes. Among the diabetic patients, 26.43% had known pre-existing diabetes, and 25.28% had new diabetes detected by fasting blood glucose test or by glucose tolerance test. Patients was mostly men between 60 - 70 years old, with higher rates of smoking, obesity, dyslipidemia, hypertension, and damaged coronary artery branches.

Article Details

References

1. Yong Zhao, Min Guo, Gang Shi. Prediabetes predicts adverse cardiovascular outcomes after percutaneous coronary intervention. European Heart journal. 2010;31: 2087-2095.
2. Małgorzata B, Lars R, Roberto F, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart. European Heart Journal. Vol 25, Issue 21. Nov 2004;1880-1890.
3. Da-Yi Hu, Chang-Yu Pan, et al. The relationship between coronary artery diseas and abnorman glucose regulation in China: The China Heart survey. European Heart Journal. 2006;27:2573-2579.
4. ADA. Older Adults: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45:S195-S207. https://doi.org/10.2337/dc 22-S013.
5. Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care. 2007;30(3):753-759.
6. Brannick B, Dagogo-Jack S. Prediabetes and cardiovascular disease: Pathophysiology and interventions for prevention and risk reduction. Endocrinol Metab Clin North Am. 2018);47:33-50.
7. Kleinherenbrink W, Osei E, den Hertog HM, Zandbergen AAM. Prediabetes and macrovascular disease: Review of the association, influence on outcome and effect of treatment. Eur J Intern Med. 2018;55:6-11. https://doi.org/10.1016/j.ejim.2018.07.001.
8. Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: Systematic review and meta-analysis. BMJ. 2016;355:i5953. https://doi.org/10.1136/bmj.i5 953.
9. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: A high-risk state for diabetes development. Lancet. 2012;379:2279-2290. https://doi.org/10.1016/S0140-6736(12)60283-9.
10. Amano T, Matsubara T, Uetani T, et al. Abnormal glucose regulation is associated with lipid-rich coronary plaque: Relationship to insulin resistance. JACC Cardiovasc Imaging. 2008;1:39-45. https://doi.org/10.1016/j.jcmg.20 07.09.003.
11. Ertan C, Ozeke O, Gul M, et al. Association of prediabetes with diffuse coronary narrowing and small-vessel disease. J Cardiol. 2014;63:29-34. https://doi.org/10.1016/j.jjcc.20 13.06.015